Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs
自体干细胞移植治疗多发性骨髓瘤后,继发性原发性恶性肿瘤风险因素的变化趋势:蛋白酶体抑制剂和免疫调节药物引入前后的变化
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2023.283202
Takamatsu, Hiroyuki; Matsuda, Tomohiro; Mizuno, Shohei; Takahashi, Tsutomu; Fuchida, Shin-Ichi; Hanamura, Ichiro; Kataoka, Keisuke; Tsukada, Nobuhiro; Matsumoto, Morio; Hangaishi, Akira; Doki, Noriko; Uchida, Naoyuki; Sawa, Masashi; Maruyama, Yumiko; Kurahashi, Shingo; Nagafuji, Koji; Harazaki, Yoriko; Kako, Shinichi; Iida, Shinsuke; Ichinohe, Tatsuo; Kanda, Yoshinobu; Atsuta, Yoshiko; Sunami, Kazutaka
肿瘤
发育与干细胞
干细胞
肿瘤免疫
多发性骨髓瘤
骨髓瘤
细胞生物学
免疫/内分泌